Perceptive Advisors LLC 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-01 8:05 pm Sale | 2023-05-24 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | Perceptive Advisors LLC | 1,488,703 1.900% | -3,844,829 (-72.09%) | Filing |
| 2022-04-25 7:02 pm Unchanged | 2022-04-25 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | Perceptive Advisors LLC | 5,333,532 10.000% | 0 (Unchanged) | Filing |
| 2022-04-20 9:17 pm Purchase | 2022-04-18 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | Perceptive Advisors LLC | 5,333,532 10.000% | 1,674,151 (+45.75%) | Filing |
| 2020-04-20 08:43 am Purchase | 2020-04-17 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | Perceptive Advisors LLC | 3,659,381 11.600% | 1,071,428 (+41.40%) | Filing |